OPKOPKO Health, Inc.

$894M

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$301M+33.1% YoY

Gross Profit

$139M46.0% margin

Operating Income

$27M9.0% margin

Net Income

$34M11.2% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+42.4%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$735M

Stockholders' Equity

$1.6B

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$301M	$226M	+33.1%
Gross Profit	$139M	$82M	+68.7%
Operating Income	$27M	-$47M	+157.5%
Net Income	$34M	-$60M	+156.4%

Revenue Segments

Service

$251M45%

Client Payers

$141M25%

Health Insurers

$84M15%

Product

$29M5%

Rayaldee

$23M4%

Government Payers

$16M3%

Patients

$10M2%

Geographic Segments

UNITED STATES

$266M88%

IRELAND

$17M6%

CHILE

$11M4%

SPAIN

$4M1%

MEXICO

$2M1%

ISRAEL

$1M0%

Other Countries

$133,0000%

OPK Q2 2020 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena